Skincare startup told to stop leaving fake reviews on Sephora website
October 21, 2019 | 9: 50pm
A skincare startup was ordered by the Federal Trade Commission Monday to stop leaving fake reviews of their products on Sephora's webpage in an effort to boost sales, a report said.
In the agreement with the FTC, Texas-based skincare company Sunday Riley agreed to not leave fake reviews on Sephora's website in the future - but the company did not have to admit it did so in the past, BuzzFeed News reported.
The FTC accused Sunday Riley employees of leaving fake, positive, reviews of their products for two years - from 2015 to 2017 - in an effort to increase sales on their site.
"Sunday Riley Skincare managers, including Respondent Sunday Riley, posted reviews of Sunday Riley brand cosmetic products on the Sephora website using fake accounts created just for that purpose, or requested that other employees do so," the FTC complaint read, according to BuzzFeed.
As part of the alleged scheme, CEO Sunday Riley told staffers to leave reviews that were "very enthusiastic without looking like a plant," according to the report.
She also instructed them to "dislike" negative reviews of their products, which would cause the review to disappear.
Under the agreement, employees of the company cannot leave a review of the products online without revealing they are a biased employee of the company.
More News in Business
Tickets for "Star Wars: The Rise of Skywalker" went on sale Monday night alongside the release of the final trailer for the highly anticipated conclusion to the nine-film epic aired during ESPN's "Monday Night Football"
Shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) shot up 4.1% during mid-day trading on Monday . The company traded as high as $188.75 and last traded at $183.53, 1,276,197 shares traded hands during trading. An increase
This week, the FTC announced a settlement with Sunday Riley Modern Skincare and its CEO, Sunday Riley, over allegations that company managers and employees posted fake reviews on Sephora.com. The FTC alleged that company managers, including
Boston-based Vertex Pharmaceuticals Inc. has achieved one of the biggest feats to date for cystic fibrosis patients - a treatment that could benefit 90 percent of patients with the rare lung disease. The FDA approved a
Dunkin' Brands Inc., the Canton-based parent company of the coffee and doughnuts chain, is expanding its partnership with California-based Beyond Meat and rolling out a plant-based sausage sandwich to 9,000 locations. The national expansion follows